Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients.
Jan Debruyne, Jacques L. De Reuck, K. Strijckmans(Ghent University), Filip De Vos(University Medical Center Utrecht), Patrick Santens, Koen J. van Laere(Ghent University Hospital), Johan Keppens Eng, Jan Versijpt(University of Groningen), J. Korf(University of Groningen), Eric Achten(Ghent University Hospital), Guido Slegers(Ghent University), Rudi Dierckx(University Medical Center Groningen)
PubMed
September 1, 2002
Cited by 41
Related Papers
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
|Molecular Neurobiology|2018|750
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
|Journal of Nuclear Medicine|2009|562
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter
|Neuro-Oncology|2022|508
A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice
|Neuroradiology|2015|299